Tempus AI

Name: Multimodal de-identified precision-oncology real-world data corpus licensable for download into a buyer's own environment: linked DNA + RNA profiles, whole-slide and radiology pathology imaging, spatial molecular data, structured EHR and clinical-notes context, treatment regimens and outcomes — with direct EHR integrations and real-time clinical feeds
Creator: Tempus AI

TEMPUS AIManage supplier listing

Multimodal de-identified precision-oncology real-world data corpus licensable for download into a buyer's own environment: linked DNA + RNA profiles, whole-slide and radiology pathology imaging, spatial molecular data, structured EHR and clinical-notes context, treatment regimens and outcomes — with direct EHR integrations and real-time clinical feeds

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Tempus AI and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care Technology
Instruments: equities
Categories: AlternativeFundamentalReference

Dataset card

Type: not stated
Format: Multimodal — Images (whole-slide pathology, radiology, spatial), Sequences (DNA/RNA variant and expression profiles), Tabular (structured EHR, labs, treatment and outcome records) and Text (clinical notes carried on ~95% of multimodal records)
Volume: 500+ petabytes total; component counts disclosed — 2M+ imaging records, ~9M whole slide images, ~400K RNA profiles, 3M connected EHR records
Users: 250+ biopharma partnerships, including 95% of the top 20 pharma companies; contributing side is a network of academic and community health systems connected by direct EHR integrations (institution count not stated on this page — request current connected-site list)
History: 10 years
Update frequency: not stated
Growth: Active — expanding multimodal modalities (spatial added to the linked set), real-time EHR feeds, AI-agent tooling launched on the data, and continued expansion collaborations with the largest pharmaceutical companies
Launched: ~2015-2016 (company founded in Chicago with a sequencing-first product; data-licensing line built on the accumulating molecular + clinical corpus thereafter)
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site